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There is a lack of suitable correlates of immune protection against Mycobacterium tuberculosis 
(Mtb) infection. T cells and monocytes play key roles in host immunity against Mtb. Thus, a 
method that allows assessing their interaction would contribute to the understanding of immune 
regulation in tuberculosis (TB). We have established imaging flow cytometer (IFC) based in 
vitro assay for the analysis of early events in T cell-monocyte interaction, upstream of cytokine 
production and T cell proliferation. This was achieved through short term stimulation of 
peripheral blood mononuclear cells (PBMC) from healthy Norwegian blood donors with 
Mycobacterium bovis Bacille Calmette-Guérin (BCG). In our assay, we examined the kinetics 
of BCG uptake by monocytes using fluorescently labeled BCG and T cell-monocyte interaction 
based on synapse formation (CD3/TCR polarization). Our results showed that BCG stimulation 
induced a gradual increase in the proportion of conjugated T cells displaying NF-κB 
translocation to the nucleus in a time dependent manner, with the highest frequency observed at 
6 hours. We subsequently tested PBMC from a small cohort of active TB patients (n=7) and 
observed a similar BCG induced NF-κB translocation in T cells conjugated with monocytes. 
The method allowed for simultaneous evaluation of T cell-monocyte conjugates and T cell 
activation as measured by NF-κB translocation, following short-term challenge of  human 
PBMC with BCG. Whether this novel approach could serve as a diagnostic or prognostic 
marker needs to be investigated using a wide array of Mtb specific antigens in a larger cohort of 
patients with different TB infection status. 
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1. Introduction
Prominent progress has been made in the fight against tuberculosis (TB) in the past decades. 
Yet, it is still among the leading infectious causes of morbidity and mortality worldwide with 
an estimated 10.4 million new cases and 1.8 million associated deaths in 2015 (WHO, 2016). 
The development of novel approaches for the control and elimination of TB is challenged by 
the lack of tools to better understand the mechanisms and outcome of the host-pathogen 
interaction. 
T cell mediated immune response of the Th-1 type is widely regarded as protective against TB 
(Kaufmann, 2006). The Th-1 cytokine, interferon gamma (IFN-γ) is considered a key 
protective cytokine based on earlier studies, in both mice and humans, which showed that 
defects in the IFN-γ signaling pathways provoked higher susceptibility to Mycobacterium 
tuberculosis (Mtb) infection and severe disease (Cooper et al., 1993; Newport et al., 1996; 
Flynn et al., 2003). Thus, many in vitro studies have focused on determining the frequency of 
Mtb specific T cells secreting IFN-γ alone, in combination with other Th-1 cytokines; IL-2 and 
TNFα measuring their level of secretion, and extent of T cell proliferation as markers of 
protection (McShane et al., 2004; Beveridge et al., 2008; Hoft et al., 2008; Smith et al., 2016).  
On the other hand, studies have shown that cytokine levels do not necessarily correlate with 
protective immunity nor predict risk of progression to active TB disease (Pai et al., 2004; Elias 
et al., 2005; Majlessi et al., 2006; Mittrucker et al., 2007; Panteleev et al., 2017). Developing 
suitable assays for the evaluation of protective immunity, risk of disease progression or 
immunogenicity of a vaccine is a priority in TB research (Centis et al., 2017).
It has long been established that T cell activation requires direct interaction between T cell 
surface receptors (TCR) and cogent peptide-major histocompatibility complex (pMHC) on the 
surface of antigen presenting cells (APCs) such as monocytes, macrophages, dendritic cells and 
B cells (Rossjohn et al., 2015; Jakubzick et al., 2017). Efficient TCR and pMHC interaction 
triggers signaling from the TCR-CD3 complex. Together with signals from costimulatory 
molecules, this results in the reorganization of T cell cytoskeletal elements with polarization of 
TCR as well as other signaling molecules towards the contact site resulting in the formation of 
an immunological synapse (IS) (Grakoui et al., 1999). The IS formation ensured sustained 
intracellular signaling in T cells, which involves translocation of transcription factors from the 
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cytoplasm to the nucleus (Kane et al., 2000). Nuclear factor kappa-B (NF-κB) is a transcription 
factor that regulates various genes involved in the host immune response; including cell 
proliferation and cytokine production (review in (Lucas et al., 2004; Tripathi and Aggarwal, 
2006)). In the resting state, NF-κB is localized in the cytoplasm and translocates to the nucleus 
upon activation, where it regulates gene transcription. It has been shown that these early events 
are among the factors that influence the quality of host immune response (Grakoui et al., 1999; 
Kane et al., 2002). Thus, assessing T cell-APC interactions and NF-κB nuclear translocation 
could be a better estimate in monitoring efficiency of immune response against TB, than 
measuring individual effector molecules. 
Here we describe the use of imaging flow cytometer (IFC) to simultaneously evaluate T cell-
monocyte conjugates and T cell activation as measured by NF-κB translocation, following 
short-term BCG challenge in vitro. We used PBMC from buffy coats of healthy Norwegian 
blood donors as well as from TB patients residing in Norway.
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2. Materials and Methods
1.2.1 Antibodies, reagents and antigens:
Antibodies used include anti-CD3 (clone OKT3), anti-CD28 (clone CD28.2, Cat# 555725, BD 
Pharmingen), anti-CD3-FITC (clone UCHT1, Cat# 21620033, Immunotools), anti-CD14-APC 
(clone MEM-15, Cat# 21279146, Immunotools), anti-IFN-γ PerCP Cy-5.5 (Clone B27, Cat # 
560704, BD biosciences), rabbit polyclonal IgG (C-20) anti-human NF-κB primary antibody 
(SC-372R, Santa Cruz Biotechnology), Alexa Fluor 594, goat anti-rabbit IgG (H+L) secondary 
antibody (Cat# R37117, Molecular Probes, Invitrogen). Fluorescent reagents include 
LIVE/DEAD Fixable Near-IR (Cat# L34976, Molecular Probes, Invitrogen), and DAPI nuclear 
stain (Cat# 00-4959-52, Thermo Fisher) and CellTrace Violet (CTV) (Cat# C34557, Molecular 
probes, Invitrogen). RPMI 1640 (Gibco, Life Technologies) complete medium supplemented 
with 10% fetal calf serum (FCS), 100 units/ml penicillin, 100 µg/ml streptomycin (all from 
GIBCOBRL®, Life Technologies™), 1M HEPES buffer solution (Gibco, Life Technologies), 
100mM Sodium-pyruvate (Gibco, Life Technologies), MEM NEAA (100x) (Gibco, Life 
Technologies), 2-Mercaptoethanol (Sigma)), Mycobacterial antigens used include: PPD for in 
vitro use (Statens Serum Institute, Copenhagen, Denmark) and ds-Red fluorescent protein 
expressing BCG (strain Myc3305, provided by Dr. Brigitte Gicquel) (Abadie et al., 2005).
1.2.2 Cell isolation and culture
Peripheral blood mononuclear cells (PBMC) from buffy coats, Oslo University Hospital, 
Norway, were isolated in high numbers by density gradient using Lymph prep (Axis–shield 
PoC AS, Cat # 1114545, Oslo, Norway) according to the manufacturer’s protocol, and 
cryopreserved at a final concentration of 10% DMSO and 20% FCS until analysis. Prior to 
experiments, PBMC were thawed, washed and re-suspended in RPMI 1640 complete medium 
supplemented with 10% FCS, and allowed to rest overnight at 370C and 5% CO2. PBMC 
(1x106 cells/ mL) were then incubated at 37oC and 5% CO2 with ds-Red expressing BCG, at a 
final concentration of 3x106 CFU/mL for 6 hrs. PBMC incubated in culture medium alone 
under the same conditions were used as unstimulated control. Cells were harvested after careful 
scraping and resuspension, and then transferred to microcentrifuge tubes for fluorochrome 
staining and acquired by IFC. 
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For the pilot experiment PBMC from treatment-naïve clinically and/or bacteriologically 
confirmed patients with active TB (n=7) were obtained from the Norwegian biobank for 
infectious diseases, Oslo University Hospital, Ulleval. The research biobank is approved by the 
Regional Ethics Committee (REK Helse-sør-øst 2008.173) and written informed consent was 
obtained from all participants prior to sample collection. The culture condition for cells from 
patients was similar to the buffy coats mentioned above.
1.2.3 In vitro T cell proliferation and IFN-γ releasing T cells
PBMCs were thawed and rested as described above and fluorescently labeled using CTV, 
according to the manufacturer’s instructions. CTV labeled cells were re-suspended in complete 
media to a concentration of 1x106 cells/mL, in the presence of IL-2 and cultured at 37o C in a 
5% CO2 atmosphere with the following antibodies or antigens added: plate bound anti-CD3 (5 
μg/ml) and anti-CD28 (1 μg/ml), PPD (10 μg/ml) or ds-Red BCG (3x106 CFU/ml). 
Unstimulated PBMC were used to assess background proliferation. Cells were then harvested 
on days 0, 4, 5, 6 and fluorochrome stained. In the preparation of IFN-γ production assay, 
brefeldin A (Sigma-Aldrich) was added to the five day culture prior to harvest and incubated 
for 4 hours. Following anti-CD3 surface staining, cells were fixed and IFN-γ intracellular 
staining was performed. Stained cells were acquired with a FACSCantoII flow cytometer using 
FACS Diva software (BD Biosciences) to determine CTV dye dilution on proliferating T cells 
and IFN-γ releasing T cells. Data analysis was performed using FlowJo version 10.0 (Tree Star 
Inc.). 
1.2.4 Imaging flow cytometry 
Throughout the protocol, wide bore pipette tips (VWR) were used. Harvested cells were 
washed once with cold FACS buffer (2% FCS, 0.1% sodium azide in PBS). To block 
nonspecific binding, cells were incubated with 10% heat inactivated human serum in FACS 
buffer for 10 minutes on ice and surface stained with anti-CD3-FITC and anti-CD14-APC 
antibodies by incubating for 20 minutes on ice and in the dark. 
For detection of intracellular NF-κB, cells were fixed in 2% paraformaldehyde for 10 minutes 
at room temperature and incubated with 0.1% Triton-X permeabilization buffer (Sigma, USA) 
for 5 minutes. Cells were then incubated with rabbit antihuman NF-κB primary antibody for 30 
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minutes followed by AF594 labeled goat anti-rabbit secondary antibody together with DAPI 
nuclear stain for 30 minutes on ice and in the dark. Single color controls were prepared from 
PBMC and used for compensation. 
An Amnis Image stream MkII 12 channel system fitted with 4 lasers was used for acquisition 
(Amnis Corporation, Seattle, WA). All acquisitions were performed at 40x magnification on a 
low stream flow rate setting using INSPIRE software (Amnis Corporation). Up to 100,000 
events were acquired from each sample. Images acquired include bright field (Channels 01 and 
09), CD3-FITC (Ch-02), ds-Red BCG (Ch-03), NF-κB AF594 (Ch-04), DAPI (Ch-07), CD14-
APC (Ch-11) and live-dead fixative (Ch-12). Cellular events were acquired by setting a gate 
using a scatter plot that allowed discriminating cells from speed beads, which were used as an 
internal calibrator for the machine. The gated cells were plotted as a histogram to exclude non-
cellular images that are DAPI negative. Single color controls of 10,000 events were acquired 
for each color in every experiment with all relevant lasers “on” and with the bright-field 
illumination and scatter laser “off”, to acquire spectral compensation samples.
1.2.5 Imaging flow cytometry data Analysis
The imaging flow cytometry data was analyzed using the IDEAS v6.1 software (Amnis 
Corporation, Seattle, WA). A compensation matrix was created using ‘raw image files’ of 
single color controls and the IDEAS compensation wizard. Events in camera focus were 
selected on the basis of ‘Gradient RMS’ feature. Following this, an ‘Area’ versus ‘Aspect ratio’ 
plot was used to identify cellular aggregates and single cells where single cells have higher 
aspect ratio while aggregates have lower aspect ratio (Ahmed et al., 2009). T cells and 
monocytes were defined within each image using individual “object masks” based on the 
respective florescence intensity of CD3 and CD14. Two cell conjugates were identified from 
the aggregates on the basis of low ‘nuclear Aspect ratio’ based on DAPI signal and two cell 
nuclear content. From the two cell nuclear content, those adjacent with one T cell were gated 
on the basis of high ‘CD3 Aspect ratio intensity’.  This subpopulation was further gated to 
identify subpopulation of one T cell conjugated with one monocyte based on high ‘CD14 
Aspect ratio intensity’.  We used TCR/CD3 polarization at the interface between a T cell and 
conjugating monocyte as marker for IS formation (Ahmed et al., 2009). To define the synapse 
within a T cell-monocyte conjugate, ‘interface’ mask was generated within the conjugating T 
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cell. The T cell-monocyte conjugate subpopulation was further separated by plotting ds-Red 
BCG fluorescent signal in CD14+ cells gated as BCG positive (BCG+) or BCG negative 
(BCG-). In order to determine NF-κB nuclear translocation in T cells, a software generated 
‘morphology’ mask based on the nuclear image was applied to the ’Similarity’ feature 
comparing the intensities of NF-κB and nuclear (DAPI) image, as previously described 
(George et al., 2006) within the T cells. 
1.2.6 Statistical analysis
The GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA, www.graphpad.com) data 
analysis software was used to do statistical comparisons, summarizations and data presentation. 
Non-parametric, two-tailed tests were used for all comparisons. Two-way analysis of variance 
was applied to comparisons with multiple time points. The Wilcoxon matched-pairs test was 
used for matched data sets while Mann-Whitney U test to determine mean differences between 
TB cases and the healthy control group. P-values < 0·05 were considered statistically 
significant.
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3.  Results 
1.3.1 Fluorescent labeled BCG induced T cell proliferation in vitro: In order to assess the 
ability of ds-Red expressing BCG to induce in vitro lymphocyte proliferation, PBMC from 
Norwegian healthy blood donors (n=6) were analyzed in a fluorescence dilution assay using 
CTV at different time points (days 0,4,5 and 6) as a bench mark for cellular immune response 
against tuberculosis (Magnani et al., 2000). 
Overlays of representative histograms showing CD4+ T cells with CTV dye dilution (CTVLow 
events) in response to BCG, PPD, anti-CD3/CD28 or unstimulated cells (UNS), at various time 
points are shown in Fig. 1A. Proportion of proliferating CD4+ T cells in response to various 
stimulants at the indicated times are summarized in Fig. 1B as line graphs. Anti-CD3/CD28 
stimulation, used as positive control, induced massive proliferation of CD4+ T cells after 4 
days of incubation, and reached close to 100% by day 6. PPD and BCG stimulation resulted in 
on average 47% and 36% CTVLow CD4+ T cells at day 6, respectively (Fig. 1B). In parallel, we 
also analyzed the Th-1 cytokine IFN-γ secretion, measured at day 5 (Fig. 1C). We observed 
that PPD (positive control) and BCG stimulation induced IFN-γ production in 14% and 11% of 
CD4+ T cells, respectively (Fig. 1 D). Taken together, our data indicated that presence of ds-
Red expressing BCG in the cell culture induced a T cell response. We thus proceeded using the 
ds-Red BCG for further investigation. 
1.3.2 IFC allowed monitoring the kinetics of BCG uptake and T cell-monocyte conjugate 
formation: We used TCR/CD3 polarization at the interface between T cells and monocytes as 
marker for immune synapse formation and NF-κB nuclear translocation as downstream effect 
after treating PBMC from healthy blood donors with ds-Red BCG and analyzed by IFC (Fig. 
2A). In order to define the optimal culture condition allowing simultaneous assessment of T 
cell-monocyte conjugates and NF-κB translocation, BCG titration with concentration up to 
4x106 CFU/ml (Supplementary Fig.1) and kinetics experiment up to 24 hours (Supplementary 
Fig. 2) were performed. The results showed a decline in the frequency of T cell-monocyte 
conjugates as the concertation increases, which was considerable at the highest concentration 
(Supplementary Fig. 1A). A similar effect was observed in the proportions of T cell-monocyte 
conjugates and CD14+ cells as incubation time extended (Supplementary Fig. 2A and 2B). 
Conversely, more NF-kB translocation was induced in T cells with increased BCG 
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concentration and incubation time. We thus limited further experiments to BCG concentration 
of 3x106 CFU/ml, which we found optimal. 
T cell-monocyte conjugates were identified as outlined in the gating strategy (Fig. 2B) and 
described in detail in the methods section. Briefly, two cell conjugates were selected by their 
low aspect ratio of the nuclear images based on DAPI signal. Of the two cell conjugates 
subpopulation, events of one T cell engaged with one monocyte were identified by their high 
CD3 and CD14 aspect ratio plotted consecutively (Fig. 2B vi, 2B vii and 2B viii).  An image 
gallery is presented showing individual images and T cell-monocyte conjugates (Fig. 3A). 
Immunological synapse (IS) formation was determined by applying ‘Interface mask’ with 
TCR/CD3 polarization at the contact site between the two cells as shown in the image gallery 
(Fig. 3A, last column) and gated as in Fig. 3B. Although there was a trend towards higher 
frequency of T cell-monocyte conjugates with polarized TCR/CD3 in BCG stimulated 
compared to unstimulated cells during the early hours of stimulation, it was terminated after 3 
hour incubation (Fig. 3C). We also examined conjugates formed between T cell and BCG 
infected monocyte based on ds-Red fluorescent detection (Fig. 3A, upper panel) and gated in 
Fig. 3D and found that the frequency of T cells conjugated with BCG positive monocytes 
increase over time, from11% after 1 hour reaching to 25% after 6 hours (Fig. 3E).
1.3.3 NF-κB translocation in T cells increased with time following in vitro BCG 
stimulation: Having found that monocytes readily take up BCG (Fig. 3), we moved on to 
analyze its impact on T cell activation. Taking advantage of the capacity of IFC to monitor 
intracellular localization of fluorescently labeled molecules, we examined NF-κB nuclear 
translocation in T cells in response to BCG stimulation and the optimal time point for this was 
determined. Cells were probed with fluorescently labelled antibody to visualize NF-κB and 
stained with DAPI to visualize the nucleus. The NF-κB signal, the nuclear mask within the T 
cell along with their composite are presented in Fig. 4A. We applied ‘Similarity feature’ to 
quantify the level of NF-κB nuclear localization based on correlation between the two images. 
Representative similarity plot histogram overlay of cells treated with BCG, PMA/ionomycin 
(positive control) and unstimulated cells (negative control) is presented to show how 
subpopulation of T cells with NF-κB translocation were identified (Fig. 4B). The proportion of 
T cells display NF-κB translocation increased over time in response to BCG stimulation. The 
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frequency of T cell conjugates displaying NF-κB nuclear translocation was an average of 4% at 
1 hour and increased to 14% at 6 hours of incubation (Fig. 4C). Thus, for subsequent 
experiments, we considered the 6 hour incubation to be optimal for measuring T cell-monocyte 
conjugate formation and induced NF-κB nuclear translocation.
1.3.4 T cell-monocyte conjugate formation in active TB cases following in vitro BCG 
stimulation: The majority of Norwegian healthy blood donors have been BCG vaccinated as 
teenagers. However, the BCG vaccination status of the blood donors tested here was unknown. 
In order to assess whether Mtb-infected individuals respond differently to BCG in the IFC 
conjugate assay, we challenged PBMC from confirmed active treatment naïve TB patients 
(n=7) with BCG for 6 hours and compared this to the results obtained using PBMCs from 
healthy blood donors (n=6). Our data showed that there was no significant difference in the 
frequency of T cell-monocyte conjugates in response to BCG stimulation, neither in TB cases 
nor in healthy controls, compared to unstimulated control cells (Fig. 5A). In addition, no 
significant difference was observed among TB cases and healthy controls in the frequency of 
total BCG induced T cell-monocyte conjugates as well as the frequency of conjugates of T cell-
BCG infected monocytes (Fig. 5B and 5C, respectively). 
1.3.5 NF-κB nuclear translocation in T cells from active TB cases: Once we identified the T 
cell-monocyte conjugates in IFC analysis, we proceeded to consider T cell conjugates for NF-
κB translocation analysis. Our data showed that the proportion of conjugates with NF-κB 
translocation was significantly higher upon BCG stimulation both in TB cases and healthy 
controls than in the spontaneously formed conjugates of unstimulated cells (UNS) (Fig. 6A and 
6B). A potential advantage of IFC evaluation of nuclear translocation of a cytosolic protein is 
the ability to detect and quantify this event in a heterogeneous population of cells at a single 
cell level or in the cell of interest interacting with another cell. When we compared NF-κB 
nuclear translocation in single T cells to T cells which were engaged in conjugate with 
monocytes, we observed that the proportion of T cells displaying NF-κB translocation was 
significantly higher in conjugated T cells than in single T cells both in active TB patients and in 
controls (Fig. 6B). Although we observed a trend towards a higher proportion of T cells 
conjugated with BCG infected monocytes and displaying NF-κB translocation in TB cases than 
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in healthy controls, this difference did not reach statistical significance in this limited number 
of tested individuals (Fig. 6C).
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4. Discussion 
The immune response against MTb is complex and involves innate and adaptive immune cells 
(Zuniga et al., 2012; Liu et al., 2017). Although studies have reported controversial findings, 
monitoring host immunity to TB mainly relies on assessing antigen induced T cell proliferation 
and cytokine secretion (Mittrucker et al., 2007; Fletcher et al., 2016; Sakai et al., 2016; Smith et 
al., 2016). Here we established an imaging flow cytometer (IFC) based in vitro assay to 
evaluate multiple parameters of the early events in T cell activation, upstream of IFN-
 production and T cell proliferation in primary human cells. 
The IFC platform, used here, is being well recognized in its application to assess large numbers 
of rare events and for analyzing co-localization of intracellular molecules (McFarlin and Gary, 
2017) and thus providing statistically robust results. In recent years, various applications of IFC 
have been reported in TB research; including assessment of phagocytosis, phagosome 
maturation and Mtb replication inside macrophage differentiated THP-1 cells (Johansson et al., 
2015; Ranjbar et al., 2015).
Being interested in biological markers for susceptibility to TB, we set out to establish an IFC-
method for analyzing the early steps of T cell response to TB antigens as a correlate of host 
immunity. If feasible, such a method could have the potential in providing information on T 
cell response not given by the currently available assays, such as lymphocytes proliferation, 
IFN- release assay or enumeration of antigen specific T cells using tetramer staining.
In our assay, we monitored T cell-monocyte interaction using TCR/CD3 polarization as a 
marker for synapse formation. Using the IFC based assay, we also monitored antigen induced 
NF-κB translocation in interacting T cells with an IS. We observed a clear effect of BCG 
stimulation in terms of higher frequency of NF-κB translocation in T cell conjugates compared 
to spontaneously formed conjugates in unstimulated cells, especially from three to six hour 
incubation. Although the effect we observed was significantly lower compared to that observed 
in T cells conjugated with monocytes, NF-κB translocation was also induced in single T cells 
that were exposed to BCG, though no difference was measured between patient cohorts. This 
finding could be explained by Toll-like receptor (TLR) mediated response, which has been 
reported be expressed in T cells and directly influence effector function upon exposure to 
bacterial products (Reynolds and Dong, 2013). 
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The main aim of this work was to establish the method itself using PBMC from healthy 
Norwegian blood donors, many of whom had previously been immunized with BCG, and thus 
were expected to harbor T cells responsive to BCG. After the method was established, we also 
tested a small number of active TB cases. Although we noticed a trend towards an increase in 
stimulation induced response in TB cases compared to Norwegian healthy controls, the number 
of individuals included here was too small for this difference to reach statistical significance.  
IFC has previously been used to assess conjugates formed between T cells with anti-CD3 
coated macrophages (Ahmed et al., 2009) or anti-CD3 coated beads (Burbach et al., 2008). 
Another group has established a method in defining immune synapse formed between purified 
CD4+ T cells and dendritic cells (Markey et al., 2015). Here, we established an IFC method to 
identify and analyze signaling events in antigen induced T cell-monocyte conjugates in PBMC 
based on TCR/CD3 polarization at the synapse. Overall, no significant difference was found in 
the proportions of T cell-monocyte conjugates between BCG stimulated and unstimulated cells. 
Although we observed an increase in conjugate formation at the early time points, we also 
experienced a gradual decline in the number of CD14+ cells over time upon BCG challenge 
(Supplementary Fig. 3), which potentially could affect the number of conjugates identified. A 
similar observation was reported by Shey and colleagues that in vitro BCG challenge lowers 
the frequency of CD14+ cell (monocytes) (Shey et al., 2012) where phagocytosis induced 
shedding from the cell surface, micropinocytosis and monocyte death has been reported as 
possible causes (Mollen et al., 2008; Webster et al., 2010). 
To our knowledge, this is the first report on the use of PBMC from humans in an IFC based 
assay to monitor the interaction between antigen presenting cell and T cell in response to live 
pathogen challenge (ds-Red BCG). The use of primary cells from healthy donors and active TB 
patients without sorting particular cell population, or using any additional inducement in the 
culture system, has the added value of measuring antigen-induced effect with minimal external 
influence. Monocytes are relatively rare in the circulation, and manipulations to enrich for the 
number of monocytes including purification by sorting has been reported to cause phenotypic 
and functional alterations (Delirezh et al., 2013), which could possibly influence on the results. 
In conclusion, we have established an IFC based method using heterogeneous cell population to 
monitor early signaling events in T cells following antigen stimulation leading to various 
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effector functions. The method allowed for simultaneous evaluation of T cell-monocyte 
conjugates and T cell activation as measured by NF-κB translocation, following short-term 
BCG challenge of PBMC samples. This high throughput setting could help to address issues 
related to tetramer staining in assessing antigen specific T cell sub-populations (Vollers and 
Stern, 2008; Rius et al., 2018). Characterizing various aspects of immune cell interaction, 
combined with the consequence on the responding effector cell, might be used to address the 
current challenge of identifying correlate immune biomarkers of protection in TB or evaluation 
of vaccine induced responses. To substantiate if this platform would be instrumental in the 
search for biomarkers of diagnostic and/or prognostic value; further investigation with a larger 
cohort including TB patients with active disease as well as latent infection will be required. 
Adding more parameters for identifying IS may help improve assay specificity and sensitivity, 
allowing for differentiation of TB immunity in clinical samples. Moreover, the issue of antigen 
specific response and loss of CD14+ signal on monocytes that we observed with BCG 
stimulation could be addressed by using fluorescently labeled Mtb antigens or peptides.  
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Figure Legends
Fig 1: Antigen induced lymphocyte proliferation and IFN-γ production in vitro: PBMC 
from healthy blood donors (n=6) labelled with CellTrace Violet (CTV) were cultured for 6 days 
in the presence of PPD, ds-Red BCG, anti-CD3/CD28 or media alone (UNS). Cells were 
harvested at various time points, fluorochrome stained and analyzed by flow cytometer for 
CTV dilution. (A) Representative histogram overlays; 0, 4, 5 and 6 days in vitro are shown here 
with the gate indicating CTVLow CD4+ events.  (B) Frequency of CD4+ T cells with CTV dye 
dilution (CTVLow events) in response to anti-CD3/CD28 (dotted line with triangles), PPD 
(dashed line with circles), ds-Red BCG (solid line with squares), or UNS (gray line with 
diamond) at days 0, 4, 5 & 6. Error bars show mean + SD. (C) Representative dot plots of IFN-
γ secreting CD4+ T cell. (D) Proportion of IFN-γ secreting CD4+ T cells in response to PPD 
(circles), ds-Red BCG (squares), anti-CD3/CD28 (inverted triangle) or UNS (triangles). 
Horizontal bars indicate median values.  
Fig 2: Assay outline and gating strategy applied to identify single cells, conjugates and 
NF-κB translocation in T cells: (A) Schematic diagram summarizing cell preparation and 
analysis. PBMC from healthy donors (n=6) were incubated with ds-Red BCG (BCG) for 6 
hours, fluorochrome stained and analyzed by IFC. (B) Cells in camera focus were selected from 
all events on the basis of gradient RMS of the bright field image (i). Single cells and cellular 
aggregates were identified by plotting ‘Area’ versus ‘Aspect ratio’ in which events with higher 
‘Aspect ratio’ are likely to be single cells while those with lower ‘Aspect ratio’ are aggregates 
(ii). Live cells were identified from the single cell sub-population based on live/dead stain (iii). 
Single T cells and monocytes were plotted from live cell sub-population based on CD3 and 
CD14 fluorescent intensities in Ch-2 and Ch-11, respectively (iv). As for single cells, live cells 
from cellular aggregates were identified on the basis of live/dead stain (v). Two-cell nuclei 
were defined by plotting ‘Intensity of DAPI’ against ‘Aspect ratio intensity of DAPI’ from the 
aggregates where those with low ‘Aspect ratio’ are gated (vi). From the subpopulation of cells 
with two nuclei, those with one T cell were identified by plotting ‘Intensity of Ch-2 
(CD3_FITC)’ against ‘Aspect ratio intensity of Ch-2’ where those with high ‘aspect ratio 
intensity’ are gated (vii). Conjugates with one T cell and one monocyte were identified by 
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plotting “intensity of Ch-11” (CD14_APC) against “Aspect ratio intensity of Ch-11” (viii), 
events with high ‘Aspect ratio intensity’ are gated as population of interest. 
Fig 3: Kinetics of BCG uptake and T cell-monocyte conjugate formation. (A) Image 
gallery, from left to right; showing bright field (BF) images in the first column, followed by T 
cells and monocytes based on CD3_FITC (green), and CD14_APC (red) fluorescent signal 
intensities, respectively. Masked images are shown in the right hand side of the respective 
images. BCG infected monocytes were identified based on detection of ds-Red fluorescent 
signal within CD14+ cells. Merged imageries are shown as; T cell conjugated with ds-Red 
BCG positive monocyte (upper panel) or monocyte with no ds-Red BCG (lower panel).  Last 
column presents DAPI images of T cell-monocyte conjugates with ‘interface’ mask. (B) 
Representative histogram overlay for TCR/CD3 polarization at 6 hours incubation of cells with 
BCG (red) or left unstimulated (UNS) (black). (C) Frequency of T cell-monocyte conjugates 
following BCG challenge (solid line) or UNS (dashed line), monitored for 6 subsequent time 
points in an hour interval. (D) Representative histograms defining BCG positive and BCG 
negative T cell-monocyte conjugates. (E), Proportion of ds-Red BCG positive conjugates 
relative to all T cell-monocyte conjugates in BCG stimulated cells, analyzed sequentially for 6 
time points. Line graphs represent mean values from 6 healthy blood donors and error bars 
show mean + SD.  
Fig 4: Kinetics of BCG induced NF-κB nuclear translocation in T cells: PBMC from 
healthy donors (n=6) were co-cultured with ds-Red BCG and analyzed as outlined in in Fig 2. 
(A). A gallery showing bright field (BF) images of two cell conjugates in the first column 
followed by T cell-monocyte conjugates as CD3+ (green)-CD14+ (red), ds-Red BCG in the 
third column followed by NF-κB (golden brown) followed by DAPI mask. The last two 
columns present nuclear mask within T cell and merged images determining NF-κB nuclear 
localization: ‘high similarity’ between fluorecent intensities of NF-κB and DAPI images 
represents translocation (top panel) and ‘low similarity’ is for no translocation (bottom panel). 
The first and third raws represnt T cells conjugated with BCG infected mocoytes while second 
and fourth raws show no BCG. (B) Representative histogram overlay for NF-κB translocation 
in T cells in response to BCG (black), PMA/ ionomycin (red) or UNS (gray) at 6 hour 
incubation. (C) Proportion of NF-κB translocation in T cell conjugates at the indicated time 
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points. Solid lines with circles represent BCG stimulated cells while dashed lines with squares 
indicated UNS. Line graphs represent mean values from 6 healthy blood donors. Error bars 
show mean + SD. Statistical significance was determined by two-way analysis of variance. 
*P<0.05, ***P<0.001, ****P<0.0001.
Fig 5: T cell-monocyte conjugates in active TB cases and healthy controls: T cell-monocyte 
conjugates were analyzed in confirmed TB cases (n=7) and healthy controls (HC) (n=6) 
following PBMC challenged for 6 hours with BCG or media (UNS). (A) Frequency of T cell-
monocyte conjugates with synapse relative to all T cell-monocyte conjugates in BCG 
stimulated and UNS pairs of TB cases and healthy contols. (B) Frequency of T cell-monocyte 
conjugates with synapse relative to all T cell-monocyte conjugates in TB cases and healthy 
controls upon BCG stimulation. (C) Proportion of ds-Red BCG positive T cell-monocyte 
conjugates in TB cases and healthy controls. Median values are indicated by horizontal lines (B 
and C). 
Fig 6: NF-κB nuclear translocation in T cells of active TB cases and healthy controls: 
PBMC from confirmed TB cases (n=7) and healthy controls (HC) (n=6) were incubated for 6 
hours. (A) Frequency of T cell conjugates displaying NF-κB translocation in response to BCG 
stimulation in active TB cases and HC relative to all T cell-monocyte conjugates. (B) 
Proportion of single T cells (s-CD3; squares) compared with T cell conjugates (c-CD3; circles) 
displaying NF-κB translocation in PBMC from active TB cases and HC in response to BCG 
stimulation. (C) Frequency of BCG positive (BCG+) T cell conjugates displaying NF-κB 
translocation in cells from active TB cases and HC. Horizontal lines (B and C) indicate median 
values. Wilcoxon matched-pairs signed rank test was used to assess changes after stimulation 
































































































































































Supplementary Fig. 1: ds-Red BCG titration for T cell-monocyte conjugate and NF-kB 
translocation analysis: Healthy donor PBMC were co-cultured with BCG at various 
concentrations for 6 hours. Cells were harvested, fluorochrome stained and the following 
parameters were assessed by IFC. Frequency of T cell-monocyte conjugates (A), T cell 
conjugates displaying NF-κB translocation (B) and single T cells displaying NF-κB 
translocation (C). Bar graphs represent samples from 2 healthy blood donors. Error bars show 
mean + SD.
Supplementary Fig. 2: Time kinetics of ds-Red BCG induced T cell monocyte interaction: 
Healthy donor PBMC were co-cultured with 3x106 CFU/ml ds-Red BCG (BCG) or media 
(UNS) for 24 hours. Cells were harvested at 1, 6 and 24 hours, fluorochrome stained and the 
following parameters were assessed by IFC.  Single CD14+ cells (A), T cell-monocyte 
conjugates (B), NF-κB nuclear translocation in T cell conjugates (C) and NF-κB translocation 
in all T cells (D) at the indicated time points. Black bars represent BCG stimulated sample 
while gray bars indicate unstimulated samples (UNS). Bar graphs represent samples from 2 
healthy blood donors. Error bars show mean + SD.
Supplementary Fig. 3: Proportions of T cells and monocytes following BCG stimulation: 
Healthy donor PBMC were co-cultured with ds-Red BCG (BCG) or media (UNS). Cells were 
harvested every hour for 6 consecutive time points fluorochrome stained and T cells and 
monocytes were asses by IFC.  Frequencies single CD14+ cells (A) and single CD3+ cells (B) 
at the indicated time points. Solid lines with circles represet BCG stimulation and dashed lines 
with squares represent unstimulated samples. Line graphs represent samples from 6 healthy 
blood donors. Error bars show mean + SD.
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